Equities

Cannabis Bioscience International Holdings Inc

CBIH:PKC

Cannabis Bioscience International Holdings Inc

Actions
IndustrialsConstruction and Materials
  • Price (USD)0.0007
  • Today's Change0.000 / 7.69%
  • Shares traded601.11k
  • 1 Year change+40.00%
  • Beta-0.1964
Data delayed at least 15 minutes, as of May 13 2024 20:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cannabis Bioscience International Holdings, Inc. provides educational and other services to the cannabis industry. The Company provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The Company’s segments include Pharmacology University Business and Alpha Research Business. Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. These trials have included drugs relating to diseases in the areas of asthma, allergies, renal disorders, neurology disorders, cardiac and vascular disorders and others.

  • Revenue in USD (TTM)56.94m
  • Net income in USD6.94m
  • Incorporated2003
  • Employees389.00
  • Location
    Cannabis Bioscience International Holdings Inc6201 BONHOMME ROAD, SUITE 466SHOUSTON 77036United StatesUSA
  • Phone+1 (214) 733-0868
  • Websitehttps://www.cbih.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hepion Pharmaceuticals Inc0.00-48.93m6.62m22.00--1.04-----12.41-12.410.001.510.00----0.00-124.91-61.43-150.17-68.82-----------4,784.140.00-------7.92------
Shuttle Pharmaceuticals Holdings Inc0.00-6.59m6.72m8.00--1.59-----0.441-0.4410.000.25240.00----0.00-90.28---104.75-------------49.560.1527-------112.71------
Oragenics Inc37.65k-20.66m6.72m5.00--2.93--178.51-8.69-8.690.01671.030.0038----7,530.00-209.44-97.60-252.98-106.24-----54,862.55-36,169.75----0.0898---71.37---44.56--51.64--
Virios Therapeutics Inc0.00-5.07m6.82m4.00---------0.2673-0.26730.00--------------------------------------56.76------
Tenax Therapeutics Inc0.00-7.71m6.95m5.00--0.1308-----33.51-33.510.0027.150.00----0.00-102.20-199.16-159.72-285.64-----------82.130.0583------30.21------
AiXin Life International Inc4.09m-2.09m7.00m207.00------1.71-0.0836-0.08360.1636-0.07650.82685.4310.0219,757.49-42.27-16.93---34.5416.2548.13-51.12-36.960.1515------51.0058.0867.18--194.59--
Cadrenal Therapeutics Inc-100.00bn-100.00bn7.05m3.00------------------------------------------------------------
Pasithea Therapeutics Corp0.00-15.51m7.24m8.00--0.3094-----12.83-13.180.0022.460.00----0.00-43.50---46.44--------------0.00-------32.23------
Cannabis Bioscience Internatnl Hlgs Inc56.94m6.94m7.27m389.000.00130.00010.78770.12760.53280.53284.294.920.591762.811.45146,384.307.83--11.73--31.96--13.24--0.685650.750.0631--12.79--177.84------
Paranovus Entertainment Technology Ltd51.46m-42.62m7.41m80.00--0.694--0.144-7.16-7.499.891.461.1859.614.15643,209.90-91.12-23.19-119.36-27.214.9223.09-77.15-24.253.97-2,465.220.00--9.689.80-45.84---21.93--
Intelligent Bio Solutions Inc2.46m-13.40m7.51m17.00--0.0904--3.05-131.37-131.3720.9126.670.18312.419.09144,726.50-99.96-80.65-157.15-224.8420.90---545.95-948.540.3864--0.1602--187.51367.97-28.00------
Trevena Inc3.13m-40.29m7.66m23.00------2.45-3.16-3.160.2611-0.44290.073.69--135,869.60-90.25-55.93-110.38-66.3546.56---1,289.25-3,134.414.66-15.431.33--847.61-11.4324.93---24.67--
National Graphite Corp0.00-1.97m7.72m0.00---------0.0221-0.02210.00-0.01930.00-------11,014.44-212.13---6,295.18---------------------1,432.70------
NuCana PLC (ADR)0.00-34.70m7.89m25.00--0.4219-----412.45-412.450.008.840.00----0.00-64.21-41.01-102.19-48.07-----------77.430.0259------13.71---21.70--
Kazia Therapeutics Ltd (ADR)14.91k-13.52m7.90m12.00--0.8584--530.05-0.8201-0.82010.00080.34920.0007--73.97---63.98-46.35-82.39-54.75-----90,714.45-497.17----0.1297--979.43-28.3118.19------
Data as of May 13 2024. Currency figures normalised to Cannabis Bioscience International Holdings Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.